Ketan Mehta, CEO of Tris Pharma, explains how the company expanded its pipeline over the past two decades.
Ketan Mehta
Advertisement
Ketan Mehta is founder and CEO of Tris Pharma.
Articles by Ketan Mehta
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
GLP-1 Patent Expiry & the Rise of Generics: Transforming the Drug Delivery Device Landscape & Procurement Strategy
2
President Trump Planning to Fire FDA Commissioner Marty Makary: Report
3
FDA Extends Priority Review of Leqembi Iqlik Subcutaneous Injection
4
Angelini Pharma Enters $ 4.1 Billion Agreement to Acquire Catalyst Pharmaceuticals
5